Merck acquires Acceleron Pharma for $11.5bn
Merck (MSD) has agreed to buy Acceleron Pharma’s outstanding shares for $180 in cash per share and a total equity…
M&A and investments
ABM announced competition for Oncology Clinical Research Support Centers
The Medical Research Agency has announced a competition, the subject of which is the establishment and development of Oncology Clinical…
Massmedica wants to build a rehabilitation hospital
Massmedica has signed an agreement to purchase the Manor and Park Complex in Bykowce, which will be transformed into a…
Medicover acquires more fitness club chains
Aiming to develop its business in the area of sport and recreation, Medicover has become the majority shareholder of the…
Neuca takes over Exom
Clinscience, a subsidiary of Neuca, buys 100 % of shares of the Italian Exom Group. Effective September 28, 2021, Cliniscience…
Samsung announced $205bn investment plan
By 2023, Samsung will invest as much as $205bn in its pharmaceutical, biopharmaceutical, semiconductor and telecommunications industries. This investment is…
Nicotine giant invests in the pharmaceutical market
US-based Philip Morris International Inc has announced the acquisition of inhalation drug development company OtiTopic. This is another pharmaceutical company…
Cardiomatics raises PLN 12.5m to develop artificial intelligence for ECG analysis
Cardiomatics, a company developing an AI tool used to analyse ECGs, has raised PLN 12.5m in funding. Up to PLN…
Medicover invests in fertility clinics in Norway
Medicover is entering the Norwegian market by acquiring a private network of infertility treatment clinics. By investing in Klinikk Hausken,…
Israel’s promising COVID drug successfully passes II Phase of research
Israel’s Covid drug EXO-CD24, subjected to Phase II trials in Athens, allowed 29 out of 30 moderate to severe patients to…
